What providers need to do to improve chronic care March 15, 2017 By Tracey Walker A West survey finds that an overwhelming number of chronic care patients say they need help managing their disease. Value-based care takes over J.P. Morgan Healthcare Conference 2017 January 23, 2017 By Marc O'Connor Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference. Study: Statin users less likely to develop kidney stones December 22, 2016 By Randy Dotinga A large new study provides more evidence that cholesterol drugs may lower kidney stone formation. How providers, payers, employers should be fighting obesity By addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term. How your pharmacy partners impact your Star Ratings August 01, 2016 By Marc O'Connor Are you tracking your prospective pharmacy partners to measure their potential impact on your Star Rating? You should be. FDA no longer supports use of niacin, fenofibric acid with statins FDA has withdrawn its approval for niacin and fenofibric acid use with statins to treat high cholesterol. Watch list 2016: Top therapeutic areas November 30, 2015 Experts say you should follow these 6 therapeutic areas. Study models way to optimize cholesterol drug value October 26, 2015 By Tracey Walker Study provides five key takeaways for managed care executives. View the five takeaways. How Express Scripts will manage pricey cholesterol drugs October 07, 2015 By Christine Blank After much criticism on the price of 2 new cholesterol-lowering drugs, Praluent and Repatha, Express Scripts said this week it will now include both drugs in its National Preferred Formulary. High cost of new PCSK9 inhibitors could plague payers September 02, 2015 By Tracey Walker The high cost of these medications could overwhelm patients and plans, according to one expert.